Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Gross Profit of -$183000.0 for Q4 2016, down 190.15% year-over-year from $203000.0 in Q1 2016, and down 154.3% quarter-over-quarter from $337000.0 in Q3 2016.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Gross Profit history runs 4 years deep, the most recent figure standing at -$183000.0 for Q4 2016.
- In Q4 2016, Gross Profit fell 190.15% year-over-year to -$183000.0; the TTM figure through Dec 2016 stood at $929000.0 (up 2.99% YoY), while the FY2016 annual figure was -$1.9 million, down 2956.06% from the prior year.
- Gross Profit for Q4 2016 stood at -$183000.0, down from $337000.0 in the prior quarter.
- The five-year high for Gross Profit was $972000.0 in Q3 2014, with the low at -$183000.0 in Q4 2016.
- The 4-year median for Gross Profit is $348500.0 (2014), against an average of $361649.1.
- Peak annual rise in Gross Profit reached 769.64% in 2016, while the deepest fall reached 190.15% in 2016.
- Viridian Therapeutics, Inc.\DE's Gross Profit stood at $723157.0 in 2013, then tumbled by 117.42% to -$126000.0 in 2014, then surged by 261.11% to $203000.0 in 2015, then sank by 190.15% to -$183000.0 in 2016.
- Business Quant data shows VRDN's Gross Profit at -$183000.0 in Q4 2016, $337000.0 in Q3 2016, and $487000.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -183,000.00 |
| Sep 30, 2016 | 337,000.00 |
| Jun 30, 2016 | 487,000.00 |
| Mar 31, 2016 | 288,000.00 |
| Dec 31, 2015 | 1.16 Mn |
| Sep 30, 2015 | 758,000.00 |
| Jun 30, 2015 | 779,000.00 |
| Mar 31, 2015 | 557,000.00 |
| Dec 31, 2014 | 726,000.00 |
| Sep 30, 2014 | 972,000.00 |
| Jun 30, 2014 | 667,000.00 |
| Mar 31, 2014 | 753,000.00 |
| Sep 30, 2013 | 723,157.00 |
| Jun 30, 2013 | 635,931.00 |